It looks like the insulin industry's price gouging racket may be coming to an end. And Sen. Chuck Grassley, R-Iowa, is leading the way.
On January 29, 2019, Grassley announced his intent to “specifically get to the bottom of the insulin price increase.” Less than a month later, the Republican senator from Iowa made good on his promise, questioning the manufacturers in a hearing and launching an investigation.
